PALI

PALI

USD

Palisade Bio Inc. Common Stock

$1.855-0.055 (-2.880%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$1.910

高値

$1.970

安値

$1.822

出来高

1.22M

企業ファンダメンタルズ

時価総額

259.3M

業種

バイオテクノロジー

United States

取引統計

平均出来高

8.45M

取引所

NCM

通貨

USD

52週レンジ

安値 $0.53現在値 $1.855高値 $3.3

関連ニュース

GlobeNewswire

Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations

Seasoned Pharmaceutical leader bringing over 24 years of experience in clinical development across autoimmune, metabolic, cardiovascular, and gastrointestinal indications Company remains focused on advancing PALI-2108

もっと見る
Palisade Bio Appoints Sharon Skare as Vice President, Global Head of Clinical Operations
GlobeNewswire

Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108

PALI-2108 is the first and only PDE4 inhibitor designed to target terminal ileum and colon for fibrostenotic Crohn's disease (FSCD) and ulcerative colitis (UC) to address significant unmet medical needs Carlsbad, CA,

もっと見る
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108
GlobeNewswire

Palisade Bio Announces Cancellation of Special Meeting of Stockholders

Carlsbad, CA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade", "Palisade Bio", or the "Company"), a clinical-stage biopharmaceutical company advancing novel therapeutics for patients

もっと見る
Palisade Bio Announces Cancellation of Special Meeting of Stockholders